Sun's Concert hits bum note as FDA imposes partial hold 2 months after $576M buyout

Sun Pharma’s $576 million Concert Pharmaceuticals buyout has rapidly run onto the rocks. Two months after closing the deal, the Indian drugmaker has revealed (PDF) a blood clot has triggered a partial FDA hold on development of Concert’s key candidate.